Company

Surrozen, Inc.

South San Francisco biotechnology company developing regenerative therapies based on Wnt biology.

About

Surrozen, Inc. was founded in 2016 and is headquartered in South San Francisco, US. It develops regenerative therapies using its Wnt biology platform, with its lead candidate SZN-043 in clinical development. Craig Parker is CEO and Claudia Janda is a co-founder. The company raised USD 50.00 mn in a Series C round on June 19, 2020, from returning and new investors including Endowment Wealth Management and Euclidean Capital.

3Funding rounds

3Investors

Sign in to see more

Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.

Sign in